|
Market Closed -
Other stock markets
|
After market 12:08:20 pm | |||
| 44.43 EUR | +3.11% |
|
44.42 | -0.02% |
| 10:21am | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Sell rating from JP Morgan | ZD |
| Dec. 02 | FMC stands out positively - Goldman very convinced | DP |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 12.64B 13.27B 11.76B 10.49B 18.67B 1,124B 20.55B 146B 54.22B 461B 49.85B 48.73B 1,979B | P/E ratio 2024 * |
19.2x | P/E ratio 2025 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise value | 22.23B 23.32B 20.68B 18.45B 32.82B 1,976B 36.12B 257B 95.32B 810B 87.63B 85.67B 3,479B | EV / Sales 2024 * |
1.15x | EV / Sales 2025 * | 1.09x |
| Free-Float |
67.83% | Yield 2024 * |
2.51% | Yield 2025 * | 3.13% |
More valuation ratios
* Estimated data
More news
Last Transcript: Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | +1.79% | ||
| 1 week | +4.46% | ||
| Current month | +5.38% | ||
| 1 month | +19.95% | ||
| 3 months | +25.94% | ||
| 6 months | +11.69% | ||
| Current year | +15.49% |
1 week
41.15
43.87
1 month
36.3943.87
Current year
32.5143.87
1 year
32.5143.87
3 years
25.9563.66
5 years
25.9581.10
10 years
25.9593.82
| Director | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 2022-12-05 |
Martin Fischer
DFI | Director of Finance/CFO | 48 | 2023-09-30 |
Jörg Häring
CMP | Compliance Officer | 54 | 2024-05-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 2016-05-11 |
A. Sorensen
BRD | Director/Board Member | 62 | 2021-05-19 |
Michael Sen
CHM | Chairman | 56 | 2023-07-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 7.48% | 202 M€ | -.--% | ||
| 1.12% | 2 M€ | +13.56% | - | |
| 0.80% | 79 M€ | -.--% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.79% | +4.46% | +13.34% | -18.69% | 13.27B | ||
| +0.13% | +0.62% | +29.83% | +41.18% | 82.99B | ||
| -1.29% | -1.66% | -13.73% | -34.35% | 74.35B | ||
| -0.51% | +0.81% | -2.96% | +64.52% | 25.79B | ||
| +1.22% | +3.30% | +190.49% | +85.03% | 22.42B | ||
| -0.22% | -0.27% | +9.89% | -17.39% | 20.13B | ||
| +1.23% | +2.37% | +15.16% | +0.84% | 19.75B | ||
| -0.71% | -0.57% | +18.61% | +4.66% | 18.03B | ||
| -1.46% | -1.95% | +56.97% | +66.47% | 13.43B | ||
| -0.46% | -0.90% | +100.01% | +91.88% | 13.51B | ||
| Average | +0.10% | +0.23% | +41.76% | +28.41% | 30.36B | |
| Weighted average by Cap. | +0.10% | +0.12% | +28.90% | +19.99% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 19.26B 20.21B 17.92B 15.99B 28.44B 1,713B 31.3B 223B 82.61B 702B 75.95B 74.25B 3,015B | 19.89B 20.87B 18.5B 16.51B 29.37B 1,769B 32.32B 230B 85.3B 725B 78.42B 76.66B 3,113B |
| Net income | 678M 711M 630M 562M 1B 60.26B 1.1B 7.83B 2.91B 24.69B 2.67B 2.61B 106B | 937M 983M 872M 778M 1.38B 83.34B 1.52B 10.83B 4.02B 34.15B 3.69B 3.61B 147B |
| Net Debt | 9.58B 10.06B 8.91B 7.95B 14.15B 852B 15.57B 111B 41.09B 349B 37.78B 36.93B 1,500B | 9B 9.45B 8.38B 7.47B 13.3B 801B 14.63B 104B 38.62B 328B 35.5B 34.71B 1,410B |
More financial data
* Estimated data
Employees
113,079
Calendar
2025-02-24
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-03 | 44.43 € | +3.11% | 425,470 |
| 24-12-02 | 43.09 € | +3.58% | 430,316 |
| 24-11-29 | 41.60 € | +0.29% | 220,663 |
| 24-11-28 | 41.48 € | -2.45% | 203,546 |
| 24-11-27 | 42.52 € | +1.31% | 162,930 |
Delayed Quote Xetra, December 03, 2024 at 04:30 am EST
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
18
Last Close Price
43.09EUR
Average target price
40.48EUR
Spread / Average Target
-6.05%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FME Stock